PDX Portal

Model Details

Patient Information for Model: BCM-PDAC-11

Model Contact

Model: BCM-PDAC-11
Model Contact: Qizhi Cathy Yao
Institution: BCM Pancreas PDX Program
Email: qizhiyao@bcm.edu

Patient Information

Clinical Timeline

Clinical Information at Collection

Clinical Biomarkers/Mutations at Collection

Pathology Information at Collection

Model Information for Model: BCM-PDAC-11

Model Details - Initial Implantation of Patient Tissue

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

Histology Information for Model: BCM-PDAC-11

There are no histology images for this model.

Metastasis Information for Model: BCM-PDAC-11

Patient

PDX

Liver

Local recurrence

Lung

Rectum

lymph node

Patient Treatment Information for Model: BCM-PDAC-11

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration	Clinical Response	Reason Stopped
25	Gemcitabine	Adjuvant	60.17	60.6	157 days	No evidence of disease	Treatment completed
30	Folfirinox	Adjuvant	60.99	61.07	29 days		Side Effects
35	Folfox	Adjuvant	61.13	61.23	36 days	Stable Disease (SD)	Treatment completed
40	Capecitabine/radiation	Adjuvant	61.3	61.4	37 days	Stable Disease (SD)	Treatment completed
45	Capecitabine	Adjuvant	61.51	61.73	80 days	Progressive Disease (PD)	Stopped due to disease progression
50	Gemcitabine/Abraxane	Adjuvant	61.8	61.85	18 days	Progressive Disease (PD)	Disease progression and clinical decompensation